Menu
GeneBe

12-112489106-G-T

Variant summary

Our verdict is Pathogenic. Variant got 27 ACMG points: 27P and 0B. PS1_Very_StrongPM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_002834.5(PTPN11):c.1530G>T(p.Gln510His) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q510P) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

PTPN11
NM_002834.5 missense

Scores

13
4
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 3.71
Variant links:
Genes affected
PTPN11 (HGNC:9644): (protein tyrosine phosphatase non-receptor type 11) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 27 ACMG points.

PS1
Transcript NM_002834.5 (PTPN11) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in ClinVar as 40567
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_002834.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr12-112489105-A-C is described in ClinVar as [Pathogenic]. Clinvar id is 13344.Status of the report is reviewed_by_expert_panel, 3 stars.
PP2
Missense variant where missense usually causes diseases, PTPN11
PP3
MetaRNN computational evidence supports a deleterious effect, 0.985
PP5
Variant 12-112489106-G-T is Pathogenic according to our data. Variant chr12-112489106-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 811634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PTPN11NM_002834.5 linkuse as main transcriptc.1530G>T p.Gln510His missense_variant 13/16 ENST00000351677.7
PTPN11NM_001330437.2 linkuse as main transcriptc.1542G>T p.Gln514His missense_variant 13/16
PTPN11NM_001374625.1 linkuse as main transcriptc.1527G>T p.Gln509His missense_variant 13/16
PTPN11XM_011538613.3 linkuse as main transcriptc.1539G>T p.Gln513His missense_variant 13/16

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PTPN11ENST00000351677.7 linkuse as main transcriptc.1530G>T p.Gln510His missense_variant 13/161 NM_002834.5 A1Q06124-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 20, 2019The PTPN11 c.1530G>T; p.Gln510His variant (rs397507550) is reported in the literature in two unrelated fetuses with prenatal symptoms of Noonan syndrome, and it was not observed in the parents of either affected fetus, indicating a de novo origin (Gezdirici 2017). Additionally, a variant giving rise to the same amino acid change (c.1530G>C; p.Gln510His) was observed in an individual affected with LEOPARD syndrome (Wakabayashi 2011). The c.1530G>T; p.Gln510His variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The glutamine at codon 510 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Additionally, other amino acid substitutions at this codon (Arg, Glu, and Pro) have been reported in individuals with Noonan syndrome or LEOPARD syndrome and are considered pathogenic (Aoki 2008, Carcavilla 2013, Ganigara 2011, Wakabayashi 2011). Based on available information, the p.Gln510His variant is considered to be pathogenic. References: Aoki Y et al. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat. 2008 Aug;29(8):992-1006. Carcavilla A et al. LEOPARD syndrome: a variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy. Rev Esp Cardiol (Engl Ed). 2013 May;66(5):350-6. Ganigara M et al. LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation. Ann Pediatr Cardiol. 2011 Jan;4(1):74-6. Gezdirici A et al. How necessary is to analyze PTPN11 gene in fetuses with first trimester cystic hygroma and normal karyotype? J Matern Fetal Neonatal Med. 2017 Apr;30(8):938-941. Wakabayashi Y et al. Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His. Am J Med Genet A. 2011 Oct;155A(10):2529-33. -
Noonan syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterMar 25, 2024- -
PTPN11-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMay 19, 2023The PTPN11 c.1530G>T variant is predicted to result in the amino acid substitution p.Gln510His. This variant has been reported in prenatal cases with cystic hygroma (Gezdirici et al. 2017. PubMed ID: 27193571; Supplemental Table S2, Leach et al. 2018. PubMed ID: 29907801) and hydrops fetalis (Supplemental Table 1, Gabriel et al. 2021. PubMed ID: 34958143). Of note, another variant impacting the p.Gln510 amino acid was also reported in prenatal cases with cystic hygroma [c.1530G>T (p.Gln510His), Supplemental Table S2, Leach et al. 2018. PubMed ID: 29907801]. In addition, another variant impacting the p.Gln510 amino acid was also reported in an individual tested for Noonan syndrome and related conditions [c.1528C>G (p.Gln510Glu), Supplemental Table S3, Leach et al. 2018. PubMed ID: 29907801]. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2020- -
Noonan syndrome Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingService de Génétique Moléculaire, Hôpital Robert Debré-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
CardioboostCm
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.56
D
BayesDel_noAF
Pathogenic
0.56
Cadd
Uncertain
26
Dann
Uncertain
1.0
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.98
D;D;D
M_CAP
Pathogenic
0.75
D
MetaRNN
Pathogenic
0.99
D;D;D
MetaSVM
Pathogenic
1.1
D
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.83
D
PROVEAN
Pathogenic
-4.4
D;.;.
REVEL
Pathogenic
0.94
Sift
Pathogenic
0.0
D;.;.
Sift4G
Pathogenic
0.0010
D;D;D
Polyphen
1.0
D;.;.
Vest4
0.98
MutPred
0.93
Loss of MoRF binding (P = 0.1112);.;.;
MVP
1.0
MPC
1.8
ClinPred
1.0
D
GERP RS
2.3
Varity_R
0.90
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-112926910; COSMIC: COSV61006865; COSMIC: COSV61006865; API